IITRI
Investigate.Collaborate.Communicate
ADVANCING SCIENCE TOGETHER
10 West 35th Street. Chicago, IL 60616
extend your your scientific team
IITRI collaborates with sponsors to establish a true partnership for the planning and execution of each study. Talk to us about your program today!
IITRI
Investigate.Collaborate.Communicate
ADVANCING SCIENCE TOGETHER
10 West 35th Street. Chicago, IL 60616
extend of your scientific team
IITRI collaborates with sponsors to establish a true partnership for the planning and execution of each study. Talk to us about your program today!
Our Experience is Exceptional
preclinical development services
Over the past 40 years IITRI has established itself as a top-quality, full-service GLP-compliant preclinical contract research organization (CRO) that provides the complete IND-enabling preclinical safety and toxicology testing programs of a large CRO, with the personalized attention of a smaller organization.
We strive to establish a true partnership with our sponsors for the planning and execution of each study.
We offer accomplished study teams, with experienced and highly accessible PhD and DABT study directors having over 15 years’ tenure, and degreed technicians to conduct your study and provide information on study progress and early results throughout the program.
IITRI specializes in GLP toxicology and safety studies, IND-enabling programs, infectious disease vaccine and therapeutic development, and inhalation toxicology programs for the biotech, pharmaceutical, and government sponsors.
NEWS AND EVENTS
IITRI Highlights: SARS-CoV-2 Publication and Two New DABTs
IITRI is proud to share recent accomplishments from two of our technical divisions. Several members of our Microbiology and Molecular Biology Division authored a recent publication entitled "Characterization of Three Variants of SARS-CoV-2 In Vivo Shows...
Sponsor News: Ascletis Announces U.S. IND Filing of Oral Antiviral ASC10 for Monkeypox Indication
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. They just announced the Investigational New Drug (IND) application of ASC10, an oral antiviral drug candidate targeting viral polymerase of monkeypox virus, has been filed with...
We’ll be at the American College of Toxicology Meeting from Nov 13-16!
Next month, we'll be back at the American College of Toxicology 43rd Annual Meeting (Nov 13-16) at the Gaylord Rockies right outside Denver, Colorado. You can find us in the exhibit hall on Monday and Tuesday at Booth #103 close to the entrance! We look...